ResMed Inc (RMD)
Debt-to-capital ratio
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 5,967,860 | 4,864,040 | 4,129,900 | 3,360,750 | 2,885,680 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
June 30, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $5,967,860K)
= 0.00
The data provided indicates that ResMed Inc's debt-to-capital ratio has consistently been zero for the dates June 30, 2021; June 30, 2022; June 30, 2023; June 30, 2024; and June 30, 2025. This persistent ratio of 0.00 suggests that the company has not relied on external debt or borrowed funds to finance its operations during this period.
A zero debt-to-capital ratio signifies that ResMed Inc's capital structure is entirely composed of equity. This high level of financial leverage, with no debt included, implies that the company is not exposed to interest obligations or debt-related financial risk. From a financial stability perspective, the absence of debt can reduce insolvency risk and improve resilience during economic downturns.
However, it also indicates that the company has not utilized debt financing, which could potentially limit its financial leverage benefits, such as tax advantages and the capacity to fund growth initiatives through debt at favorable interest rates. Overall, the static zero ratio over multiple years underscores ResMed Inc's conservative capital structure, emphasizing reliance on internal funds and equity rather than external borrowings.
Peer comparison
Jun 30, 2025